Ten challenging questions about SARS-CoV-2 and COVID-19.


Journal

Expert review of respiratory medicine
ISSN: 1747-6356
Titre abrégé: Expert Rev Respir Med
Pays: England
ID NLM: 101278196

Informations de publication

Date de publication:
09 2020
Historique:
pubmed: 17 6 2020
medline: 6 10 2020
entrez: 16 6 2020
Statut: ppublish

Résumé

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) recently introduced as a global public health problem by the World Health Organization (WHO). The virus outbreak has been documented around the world. Updating data in different aspects of the virus could force us to revise our idea about the main questions concerning coronavirus disease-19 (COVID-19). Although our knowledge about the SARS-CoV-2 and COVID-19 is largely based on the very limited data, the information is growing rapidly. The renewed answers to the specific research questions concerning updating data not only reveal gaps for future research but also re-categorized our information. Here, we attempt to briefly discuss 10 important questions about SARS-CoV-2 and COVID-19. Since our knowledge about different aspects of SARS-CoV-2 appears to be in its infancy and is rapidly changing, the provision of the right data is more difficult in this regard. However, we try to rely on results from more extensive research to answer the main questions about this new virus. Therefore, further studies, particularly in the context of the virus pathogenesis, diagnosis, treatment, and vaccine development, are warranted.

Identifiants

pubmed: 32536226
doi: 10.1080/17476348.2020.1782197
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

881-888

Auteurs

Majid Teymoori-Rad (M)

Department of Virology, School of Public Health, Tehran University of Medical Sciences , Tehran, Iran.

Saeed Samadizadeh (S)

Infectious Diseases Research Centre, Golestan University of Medical Sciences , Gorgan, Iran.
Department of Microbiology, School of Medicine, Golestan University of Medical Sciences , Gorgan, Iran.

Alijan Tabarraei (A)

Infectious Diseases Research Centre, Golestan University of Medical Sciences , Gorgan, Iran.

Abdolvahab Moradi (A)

Infectious Diseases Research Centre, Golestan University of Medical Sciences , Gorgan, Iran.

Mahsa Bataghva Shahbaz (MB)

Roberts Research Institute and School of Biomedical Engineering, Western University , London, Canada.

Alireza Tahamtan (A)

Infectious Diseases Research Centre, Golestan University of Medical Sciences , Gorgan, Iran.
Department of Microbiology, School of Medicine, Golestan University of Medical Sciences , Gorgan, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH